# Heparin Sodium and Dextrose

NDC: 0409-4520
Generic name: HEPARIN SODIUM
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221212

FDA application: NDA019339

## Active ingredients

- HEPARIN SODIUM: 10000 [USP'U]/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-4520"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-4520
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eede8a0c-5ae6-4166-84b3-12081405f08e
